Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The PEP-TALK trial has been given the green light and is now open to recruitment.

The PEP-TALK Trial has opened to recruitment.

 

PEP-TALK is a multi-centre randomised controlled trial to assess the effectiveness of a group exercise and behaviour-change intervention to increase physical activity in people following a Total Hip Replacement or a Total Knee Replacement. Half the patients involved in the trial will receive the normal rehabilitation after hip or knee replacement which is attendance to 6 exercise group sessions provided weekly from up to 4 weeks after the operation. The other half of patients involved in the trial will receive this plus 6, 30-minute group discussions, where patients will be supported to talk about what helps or hinders them being more physically active and to work out ways which may help them become more active in their recovery.

 

Further information can be found on the trial website: https://peptalk.octru.ox.ac.uk/

Similar stories

SCIENCE spreads across the world

Oxford Trauma are pleased to open their first overseas site for the SCIENCE study.

Treatment choice for rotator cuff disorders could create efficiency and savings for the NHS

A trial that evaluated the clinical and cost effectiveness of physiotherapy treatments for rotator cuff disorders suggests cost savings can be made while maintaining positive patient outcomes.

PRoCuRe opens to recruitment

The Partial Rotator Cuff Tear Repair Trial (PRoCuRe) is open to recruitment at Oxford University Hospitals NHS Foundation Trust after achieving OCTRU Green Light approval!

IMP-MEL Trial given Green Light to open

OCTRU have now given Green Light approval for IMP MEL to open. This is a phase 1 first-in-human dose finding/randomised phase 2 study of IMM60 and pembrolizumab in advanced melanoma and NSCLC.

WISE opens to recruitment

The WISE Study - Wrist Injury Strengthening Exercise: a randomised multicentre feasibility study of resistance exercise versus usual care for optimising function after distal radius fracture in adults aged 50 years or over has now received OCTRU Green Light approval and has opened to recruitment.